929P The efficacy and safety of surufatinib combined with chemotherapy in the first-line treatment of advanced periampullary carcinoma: A single arm, prospective, exploratory clinical study. - Wang, Q.; Tu, M.; Lu, N.; Xu, D.; Wu, Y.; Jiang, K. (Annals of Oncology, 2025)